Pollak MN - Search Results

1

BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.

Beauchamp MC, Knafo A, Yasmeen A, Carboni JM, Gottardis MM, Pollak MN, Gotlieb WH. Beauchamp MC, et al. Among authors: pollak mn. Gynecol Oncol. 2009 Nov;115(2):193-8. doi: 10.1016/j.ygyno.2009.07.009. Epub 2009 Aug 21. Gynecol Oncol. 2009. PMID: 19699512

2

Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089.

Huynh H, Pollak M, Zhang JC. Huynh H, et al. Int J Oncol. 1998 Jul;13(1):137-43. doi: 10.3892/ijo.13.1.137. Int J Oncol. 1998. PMID: 9625815

3

Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.

Rozen F, Zhang J, Pollak M. Rozen F, et al. Int J Oncol. 1998 Oct;13(4):865-9. doi: 10.3892/ijo.13.4.865. Int J Oncol. 1998. PMID: 9735418

4

Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.

Rozen F, Pollak M. Rozen F, et al. Int J Oncol. 1999 Sep;15(3):589-94. doi: 10.3892/ijo.15.3.589. Int J Oncol. 1999. PMID: 10427145

5

Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells.

Camirand A, Pollak M. Camirand A, et al. Br J Cancer. 2004 May 4;90(9):1825-9. doi: 10.1038/sj.bjc.6601682. Br J Cancer. 2004. PMID: 15150607 Free PMC article.

6

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.

Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Gotlieb WH, et al. Among authors: pollak mn. Gynecol Oncol. 2006 Feb;100(2):389-96. doi: 10.1016/j.ygyno.2005.09.048. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300820

7

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Zakikhani M, et al. Cancer Res. 2006 Nov 1;66(21):10269-73. doi: 10.1158/0008-5472.CAN-06-1500. Epub 2006 Oct 23. Cancer Res. 2006. PMID: 17062558

8

Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia.

Schaffer A, Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak MN, Franco EL; Biomarkers of Cervical Cancer Risk Study Team. Schaffer A, et al. Among authors: pollak mn. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):716-22. doi: 10.1158/1055-9965.EPI-06-0924. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416762

9

The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.

Levitt RJ, Zhao Y, Blouin MJ, Pollak M. Levitt RJ, et al. Cancer Lett. 2007 Oct 8;255(2):300-6. doi: 10.1016/j.canlet.2007.05.006. Epub 2007 Jun 28. Cancer Lett. 2007. PMID: 17602833

10

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. Gotlieb WH, et al. Among authors: pollak mn. Gynecol Oncol. 2008 Aug;110(2):246-50. doi: 10.1016/j.ygyno.2008.04.008. Epub 2008 May 21. Gynecol Oncol. 2008. PMID: 18495226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters